Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial)

Harsimran S. Singh, George D. Dangas*, Giulio Guagliumi, Jennifer Yu, Bernhard Witzenbichler, Ran Kornowski, Cindy Grines, Bernard Gersh, Darius Dudek, Roxana Mehran, Gregg W. Stone

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science